tiprankstipranks
JW LIFESCIENCE CORPORATION (KR:234080)
:234080
South Korea Market
234080
JW LIFESCIENCE CORPORATION
RESEARCH TOOLSreports

JW LIFESCIENCE CORPORATION (234080) Financial Statements

― Followers

JW LIFESCIENCE CORPORATION Financial Overview

JW LIFESCIENCE CORPORATION's market cap is currently ₩171.26B. The company's EPS TTM is $1681.33; its P/E ratio is 6.55; and it has a dividend yield of 4.99%. JW LIFESCIENCE CORPORATION is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 257.83B₩ 222.48B₩ 206.86B₩ 188.93B₩ 169.82B
Gross Profit₩ 69.77B₩ 57.51B₩ 52.35B₩ 48.12B₩ 49.16B
Operating Income₩ 33.30B₩ 35.86B₩ 30.86B₩ 27.09B₩ 28.42B
EBITDA₩ 51.41B₩ 76.82B₩ 50.83B₩ 43.73B₩ 37.57B
Net Income₩ 28.61B₩ 43.99B₩ 28.14B₩ 14.96B₩ 12.91B
Balance Sheet
Cash & Short-Term Investments₩ 10.49B₩ 9.62B₩ 28.35B₩ 28.87B₩ 5.08B
Total Assets₩ 318.21B₩ 325.32B₩ 255.84B₩ 252.94B₩ 219.47B
Total Debt₩ 50.57B₩ 69.24B₩ 46.31B₩ 67.20B₩ 46.49B
Net Debt₩ 42.19B₩ 61.73B₩ 26.09B₩ 63.28B₩ 41.56B
Total Liabilities₩ 97.63B₩ 124.88B₩ 96.44B₩ 112.61B₩ 87.97B
Stockholders' Equity₩ 220.58B₩ 200.44B₩ 159.39B₩ 140.33B₩ 131.49B
Cash Flow
Free Cash Flow₩ 27.98B₩ 40.38B₩ 29.31B₩ 5.84B₩ 10.77B
Operating Cash Flow₩ 40.54B₩ 50.69B₩ 37.57B₩ 14.13B₩ 30.17B
Investing Cash Flow₩ -13.37B₩ -68.03B₩ 8.04B₩ -28.25B₩ -22.81B
Financing Cash Flow₩ -26.30B₩ 1.78B₩ -29.31B₩ 13.12B₩ -5.03B
Currency in KRW

JW LIFESCIENCE CORPORATION Earnings and Revenue History

Income Statement >

JW LIFESCIENCE CORPORATION Debt to Assets

Balance Sheet >

JW LIFESCIENCE CORPORATION Cash Flow

Cash Flow >

JW LIFESCIENCE CORPORATION Forecast EPS vs Actual EPS

Earnings >